Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases - Rilegato

Rilegato

ISBN 10: 9811643911 ISBN 13: 9789811643910

Casa editrice: Springer Nature, 2022

Riassunto

<p>This book describes the growing clinical and healthcare relevance of nano-therapeutics in treating respiratory diseases. It begins with a brief introduction on the different types of nanoparticles in respiratory disease conditions. It further discusses the current trends in understanding the disease pathology using different in vitro and in vivo models, which are important towards the onsite clinical applications and development of new therapeutics. The book includes exciting topics such as formulation of these nanoparticles, targeting various organelles etc. It also describes the future prospects and challenges in the field.&nbsp;Different chapters are written by researchers actively working in the area of pulmonary diseases. This book is designed to address the requirements of both beginners and specialized scientists involved in pulmonary research. The contents include basic concepts followed by advanced state-of-art monitoring and treatment of diseases. The book is meant for researchers and industry experts in nanotechnology, pharmaceutical sciences and drug design.</p><p></p><p></p>

Su questo libro

Informazioni sull?autore

Dr Dinesh Kumar Chellappan currently works at the International Medical University (IMU), Kuala Lumpur, Malaysia. He has more than 12 years of teaching experience in the current profession. He completed his PhD in Pharmaceutical Sciences, from the Manipal University, India in 2009. Prior to that he did Masters in Pharmacy from the same university. He has worked on several research projects especially in the field of diabetes and inflammation. He has published more than 100 publications in reputed research journals with a cumulative impact factor of &gt;200. He also has presented a number of papers at conferences and have received research grants, both at national and international levels, to conduct research. In addition, he is a reviewer and is on the editorial board of several research journals. His area of expertise lies in preparation of standardized plant extracts, isolation of phytoconstituents, characterization and structural elucidation of phytoconstituents, pharmacological research of standardized extract for its various activities.<div><br></div><div>Dr. Kamal Dua is currently a lecturer at the Graduate School of Health (Pharmacy), University of Technology Sydney (UTS), Australia. Dr Dua is also a group leader, Drug Delivery node, Centre for Inflammation, The Centenary Institute of Cancer Medicine and Cell Biology/UTS. He holds two doctoral degrees in Pharmaceutical Sciences and Immunology & Microbiology, Master of Pharmacy, MPharm (with a Major in Pharmaceutics), and Bachelor of Pharmacy (BPharm). He has also been awarded four professional diplomas in the areas of Clinical Research, Product Development, Drug Regulatory Affairs & Documentation and Intellectual Property Rights (IPR). He has received various awards and fellowships for his academic and professional achievements, including the Excellence Award in Pharmacy (2018); Young Scientist Award (2011); and the Sri. K. Sri Harsha Memorial Gold Medal & Rank Certificate (2004). His research experience spans more than 12 years, which lies on the interdisciplinary boundary between the acquired extensive knowledge on the application of the principles of pharmacy (primarily formulation and pharmaceutics) to biomedical sciences (immunology and microbiology). He has published 90 peer-reviewed manuscripts in various respected pharmacy and pharmacology journals and has authored 2 books, 4 book chapters.</div><div><br></div><div>Dr Md Faiyazuddin has over 13 years of experience as an entrepreneur, academician and researcher with proficiency in Pharmaceutical Nanotechnology & Clinical Nanomedicine. Dr Faiyazuddin is the Head of Asia Office & Global Business Director, Nano Drug Delivery®, Baltimore, MD 1851, USA.&nbsp; Previously, he served as the Principal, School of Pharmacy, RCU, Jharkhand, and Bihar College of Pharmacy, Magadh University, Patna. He hold several leading positions including Principal Investigator- Nanopharmaceutical drug delivery research lab at the Integral University, Lucknow, Assistant Professor & Quality Coordinator-College of Pharmacy, University of Hail, KSA and Assistant Professor, Faculty of Pharmacy, Integral University, Lucknow, India. Dr Faiyazuddin is the founder president of the International Pharmaceutical Forum. He is an associate member of Institute of Nanotechnology, Scotland; British Society of Nanomedicine, International Society of Aerosol in Medicine, and American Lung Association, Chicago. His research interests include nanoplatform for potential molecules for lungs delivery, oral delivery of cytotoxic drugs for solid tumors in novel biodegradable polymeric nanoparticles, and nanocarriers for skin delivery. His research has received funding from Department of Science & Technology, Govt. of India, Deanship of Scientific Research, UoH, Saudi Arabia, and other international foundations. Dr. Faiyazuddin has published more than 70 peer-reviewed manuscripts in various international journals and has authored 2 books, 5 book chapters. He has a number of awards and accolades to his name. He is the organizing member of various international conferences in Middle east and Europe.&nbsp; Dr. Faiyazuddin is editor of journals like Journal of Nanomedicine and Biotherapeutic Discovery, Pharmacologia, Intellectual Property Rights: Open Access, Clinical Research and Regulatory Affairs, International Journal of Pharmacy Teaching and Practices and, International Journal of Research in Pharmaceutical & Nanosciences, Journal of Basic & Applied Research.</div><div><br></div>

Dalla quarta di copertina

This book describes the growing clinical and healthcare relevance of nano-therapeutics in treating respiratory diseases. It begins with a brief introduction on the different types of nanoparticles in respiratory disease conditions. It further discusses the current trends in understanding the disease pathology using different in vitro and in vivo models, which are important towards the onsite clinical applications and development of new therapeutics. The book includes exciting topics such as formulation of these nanoparticles, targeting various organelles etc. It also describes the future prospects and challenges in the field.&nbsp;Different chapters are written by researchers actively working in the area of pulmonary diseases. This book is designed to address the requirements of both beginners and specialized scientists involved in pulmonary research. The contents include basic concepts followed by advanced state-of-art monitoring and treatment of diseases. The book is meant for researchers and industry experts in nanotechnology, pharmaceutical sciences and drug design.

Dettagli dell?edizione

• Editore: Springer Nature
• Data di pubblicazione: 2022
• ISBN 10: 9811643911
• ISBN 13: 9789811643910
• Rilegatura: Copertina rigida
• Lingua: Inglese
• Numero edizione: 1
• Numero di pagine: 668
• Redattore: Chellappan Dinesh Kumar, Pabreja Kavita, Faiyazuddin MD.
• Contatto del produttore: non disponibile